F J Castellino Selected Research

Atherosclerosis

1/2001

Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

F J Castellino Research Topics

Disease

5	Hemorrhage 11/2013 - 02/2000
4	Inflammation (Inflammations) 12/2006 - 06/2000
3	Fibrosis (Cirrhosis) 01/2018 - 02/2001
3	Thrombosis (Thrombus) 11/2013 - 06/2000
3	Vascular System Injuries 05/2001 - 01/2001
2	Wounds and Injuries (Trauma) 12/2016 - 11/2001
2	Disseminated Intravascular Coagulation 12/2016 - 12/2006
2	Neoplasms (Cancer) 01/2014 - 10/2000
2	Afibrinogenemia (Fibrinogen Deficiency) 03/2007 - 11/2001
2	Neointima 01/2001 - 01/2001
2	Acute Lung Injury 01/2001 - 09/2000
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2001 - 09/2000
1	Respiratory Insufficiency (Respiratory Failure) 12/2016
1	Heart Arrest (Cardiac Arrest) 12/2016
1	Postpartum Hemorrhage 12/2016
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 11/2013
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2009
1	Pathologic Processes 07/2009
1	Ischemic Stroke 07/2009
1	Necrosis 02/2009
1	Adenoma (Adenomas) 11/2007
1	Colorectal Neoplasms (Colorectal Cancer) 11/2007
1	Disease Susceptibility (Diathesis) 01/2003
1	Parkinson Disease (Parkinson's Disease) 09/2001
1	Epilepsy (Aura) 09/2001
1	Stroke (Strokes) 09/2001
1	Alzheimer Disease (Alzheimer's Disease) 09/2001
1	Chronic Pain 09/2001
1	Perinatal Death 07/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2001
1	Carcinoma (Carcinomatosis) 01/2001
1	Atherosclerosis 01/2001
1	Lymphoma (Lymphomas) 01/2001
1	Corneal Neovascularization 10/2000
1	Fibrosarcoma 10/2000
1	Infections 06/2000
1	Protein C Deficiency 04/2000

Drug/Important Bio-Agent (IBA)

6	FibrinIBA 01/2018 - 01/2001
3	Fibrinogen (Factor I)FDA Link 01/2018 - 01/2001
3	CollagenIBA 02/2009 - 01/2001
3	Plasminogen Activators (Plasminogen Activator)IBA 11/2001 - 06/2000
2	Dacarbazine (DIC)FDA LinkGeneric 12/2016 - 07/2001
2	Thromboplastin (Tissue Factor)IBA 01/2014 - 12/2006
2	ThrombomodulinIBA 01/2014 - 07/2009
2	Factor VII (Proconvertin)IBA 02/2009 - 04/2000
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 11/2007 - 10/2000
2	Factor X (Stuart Factor)IBA 01/2003 - 02/2000
2	PlasminogenIBA 11/2001 - 06/2000
2	Proteins (Proteins, Gene)FDA Link 07/2001 - 06/2000
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2001 - 09/2000
1	Thrombin FDA Link 01/2014
1	Platelet Membrane GlycoproteinsIBA 01/2014
1	AnticoagulantsIBA 01/2014
1	Thrombin Receptors (Thrombin Receptor)IBA 01/2014
1	Endothelial Protein C ReceptorIBA 01/2014
1	Factor XI (Plasma Thromboplastin Antecedent)IBA 11/2013
1	AntibodiesIBA 11/2013
1	ferric chlorideIBA 11/2013
1	Protein CIBA 07/2009
1	Protein SIBA 07/2009
1	Indicators and Reagents (Reagents)IBA 11/2007
1	LDL CholesterolIBA 03/2007
1	Factor VIIa (Activated Factor VII)IBA 12/2006
1	Peptide Hydrolases (Proteases)FDA Link 12/2006
1	LipopolysaccharidesIBA 12/2006
1	estropipate (Ogen)FDA LinkGeneric 11/2006
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2001
1	Pharmaceutical PreparationsIBA 09/2001
1	Glutamic Acid (Glutamate)FDA Link 09/2001
1	Plasminogen Activator Inhibitor 1IBA 01/2001
1	SolutionsIBA 01/2001
1	CopperIBA 01/2001
1	Antineoplastic Agents (Antineoplastics)IBA 01/2001
1	Plasminogen InactivatorsIBA 10/2000
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2000
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2000
1	Fibrinolysin FDA Link 06/2000

Therapy/Procedure

1	Therapeutics 12/2016
1	Resuscitation 12/2016
1	Transplantation 01/2003
1	Lasers (Laser) 05/2001